Eli Lilly | LLY - Activos Circulantes

Precio De Mercado
965.87
Cambio Diario
31.27 3.35%
Mensual
3.24%
Anual
17.27%
Q2 Expectativa
865.04




Activos Circulantes Cambio Fecha
AbbVie USD 29.06B 523M 2025-12
Abbott USD 25.51B 488M 2026-03
ALKERMES USD 1.93B 187.5M 2025-12
Amgen USD 31.48B 2.42B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Baxter International USD 6.85B 25M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Bristol-Myers Squibb USD 27.21B 2.18B 2026-03
Coherus Biosciences USD 206.71M 254.25M 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 54.84B 794M 2026-03
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Glaxosmithkline GBP 23.59B 390.44M 2025-12
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merck USD 43.52B 4.04B 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Zoetis USD 6.77B 185M 2025-12